Bausch Health Companies Inc. (BHC) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $259K. Most recent filing: Aug. 20, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 20, 2026 filed Aug. 19, 2026 | Lenar Aimee J. President, US Pharma | −$258,894 | 36,827 | −10% | Yes | |
|
|
||||||
| July 20, 2026 filed July 17, 2026 | Lenar Aimee J. President, US Pharma | $25,406 | 5,260 | −1% | No | |
|
|
||||||
| July 17, 2026 filed July 15, 2026 | Lenar Aimee J. President, US Pharma | $114,402 | 23,395 | −6% | No | |
|
|
||||||
| July 15, 2026 filed July 14, 2026 | LEE STEVEN HYOSIG SVP, Controller & CAO | $14,844 | 3,125 | −4% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free